Posted on 9/18/18
Just Biotherapeutics Announces Product Development and Manufacturing Agreement with Pandion Therapeutics
SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Just Biotherapeutics, Inc. (Just), an integrated design company focused on technologies that will accelerate development of biotherapeutics and substantially reduce their manufacturing . . .
Posted on 9/18/18
Better Buy: Celgene Corp. vs. Biogen
The biopharmaceutical sector is expected to be one of the most profitable areas for investors over the next decade. Ground-breaking technologies such as next-generation gene-editing systems, . . .
Posted on 9/17/18
Avista Pharma Solutions Expands Service Offerings in New England
BOSTON--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. has announced upgrades to its Agawam, MA facility, increasing its analytical chemistry footprint while expanding its compendial and raw material testing capabilities. . . .
Posted on 9/17/18
MIACH Orthopaedics Secures $22.5 Million Series A Financing
BOSTON--(BUSINESS WIRE)--MIACH Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, announced today it completed $22.5 million in financing. . . .
Posted on 9/17/18
Nationally Recognized Pharmaceutical Executives Launch Commercial Drug Sourcing Firm, Avayle CTS
DOVER, Mass.--(BUSINESS WIRE)--Pharmaceutical and biotechnology companies worldwide have a new strategic resource for efficient, cost-effective commercial drug sourcing services. Avayle CTS, led by executives with decades . . .
Posted on 9/17/18
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
The market for complex therapies that train living cells to attack cancer is taking baby steps, but there's still a lot of enthusiasm for experimental drugs . . .
Posted on 9/17/18
Rubius Therapeutics Added to Russell 2000 and 3000 Indexes
CAMBRIDGE, Mass., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, . . .
Posted on 9/13/18
Tufts Health Plan Receives ISO 27001 Certification
For the fifth year in a row, Tufts Health Plan has received ISO 27001 certification, one of the most rigorous certifications related to information security management."ISO . . .
Posted on 9/13/18
Scapa Healthcare To Acquire Advanced Wound Dressing Facility in the UK
Scapa Healthcare, a trusted strategic outsource partner of skin friendly turn-key solutions, has signed an agreement to purchase the Systagenix manufacturing facility located in Gargrave
Posted on 9/13/18
Merck & Co Inc. (MRK) Management Presents at Morgan Stanley Global Healthcare Conference 2018 - Brokers Conference Transcript
Merck & Co Inc. (NYSE:MRK) Company Conference Presentation September 12, 2018 3:40 PM ETExecutivesKen Frazier - Chairman and Chief Executive OfficerRoger Perlmutter - President of Merck . . .
Posted on 9/13/18
Mitra Biotech Announces Partnership with Glenmark Pharmaceuticals
Mitra Biotech today announced a partnership with Glenmark Pharmaceuticals focused on advancing Glenmark's proprietary immuno-oncology drug pipeline utilizing Mitra's CANscriptTM platform.CANscript is a human, immune-relevant ex . . .
Posted on 9/12/18
Quanterix Announces Termination of License Agreement with bioMérieux
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its . . .
Posted on 9/12/18
Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award
CAMBRIDGE, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today congratulated Dr. C. David Allis and Dr. Michael Grunstein, the co-recipients of . . .
Posted on 9/12/18
Cantina Named Digital Design And Development Partner For 2018 Connected Health Conference
The Personal Connected Health Alliance(PCHAlliance) announced today that Cantina Consulting has joined the 2018 Connected Health Conference as its digital design and development partner. The focus . . .
Posted on 9/12/18
Cigna Announces Cigna Ventures with $250 Million to Fund Transformative Innovation and Growth for Health Care
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Today, global health service company Cigna (NYSE: CI) announced the launch of Cigna Ventures, a corporate venture fund focused on transformative and innovative health . . .
Posted on 9/12/18
Evolent Health To Acquire New Century Health
Evolent Health, Inc. (NYSE: EVH) – Evolent Health, Inc. and NCIS Holdings, Inc. and New Century Investment, LLC announced today that they have entered into a . . .
Posted on 9/12/18
U.S. Department of Defense Awards $3.3 Million Grant to Alivio Therapeutics
BOSTON--(BUSINESS WIRE)--Alivio Therapeutics, an affiliate of PureTech Health plc (LSE: PRTC) developing therapies to treat inflammatory disorders through targeted disease immunomodulation, today announced a $3.3 million . . .
Posted on 9/11/18
Health Dialog Decision Aids Receive Certification from Washington State Health Care Authority
BOSTON--(BUSINESS WIRE)--Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, announced today that the Washington State . . .
Posted on 9/11/18
Bio2 Technologies Secures Series C Financing Led by DSM Venturing
Bio2 Technologies, Inc., a privately held orthopedics company, announced today the closing of its Series C equity financing led by DSM Venturing.
Posted on 9/11/18
Casma Therapeutics Announces Partnership with Fondazione Telethon
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced a research collaboration with Fondazione Telethon, . . .
Posted on 9/11/18
ImmusanT Expands Platform to Type 1 Diabetes with Investment from JDRF T1D Fund
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy platform to translate and deliver first-in-class peptide-based immune therapies to people living . . .
Posted on 9/11/18
Growth Ally Announces Comprehensive Health Industry Learning (CHIL) Workshops Led by Frank Ingari
BOSTON--(BUSINESS WIRE)--Growth Ally LLC announced today the launch of the Comprehensive Health Industry Learning (CHIL) Workshop, an intensive 2-day program intended to provide a strategic and . . .
Posted on 9/11/18
Provident Healthcare Partners Advises OrthoBethesda Through Its Partnership With Atlantic Street Capital
OrthoBethesda, a premier provider of orthopedic services in the greater Washington, DC region, has partnered with Atlantic Street Capital
Posted on 9/11/18
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of diseases . . .
Posted on 9/17/18
Massachusetts Health Plans Select CAQH Solution to Increase Provider Directory Accuracy
HealthCare Administrative Solutions (HCAS), a non- profit organization of Massachusetts based health plans, has selected DirectAssure, a CAQH Solution, to improve the quality and timeliness of . . .

